Company identity
Company number 05341664
Company profile
UK company 05341664, incorporated on 25 January 2005.
Bot Verification
Paraytec Limited is a UK company with status active founded in 2005.
Company number 05341664
Updated 07 Jul 2026 09:49
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
CS01 | Transaction MzU0MDI5OTQ0MmFkaXF6a2N4
Published 21 Aug 2026 15:24
TM01 | Transaction MzUzOTMzMjEzOWFkaXF6a2N4
Published 18 Aug 2026 11:59
Company registered at Companies House
1 Mar 2019 to 31 Aug 2021
Awaiting Public Project Summary
1 Oct 2017 to 30 Jun 2018
Can we detect and monitor bladder cancer with a urine test? For many patients with bladder cancer (BC), their cancer comes back after treatment and so they have to be regularly checked. These patients are checked with a cystoscope. This is a long thin flexible tube with a light and a camera at the end that is inserted into the urethra (the tube that carri...
1 Jun 2017 to 31 Mar 2020
Biotherapeutic drugs are an increasingly important class of new medicines and their effective action in the therapeutic treatment of disease has attracted interest from both academic and industry sectors. Despite the overwhelming benefits to patients, the availability of these drugs at point-of-care is inextricably linked to their affordability. Currently...
1 Feb 2014 to 31 Jan 2015
The driver for this project is the need for technical innovation, as identified by users in the pharmaceutical industry, for imaging dissolution of complex tablet formulations. This project will develop the prototype of new analytical instrument to allow rapid measurement and characterisation of how complex formulations release their active components in ...
1 Jul 2013 to 31 May 2014
This project brings together the innovative detection technology of Paraytec Ltd with the target recognition technology provided by Aptamer Diagnostic Ltd to create the next generation of detection instruments. These novel platforms will allow rapid field and point-of-care based diagnosis based on multiple markers of disease or contamination. Simultaneous...
1 Mar 2013 to 30 Jun 2013
To develop a demonstrator version of a miniaturized instrument for rapid in vitro release testing of semi-solid formulations in pharmaceuticals, biopharmaceuticals, cosmetics and personal care products. Current methods are slow, resource intensive and require large amounts of sample. The project will address all of these shortfalls, develop new competenci...
1 May 2011 to 31 Jul 2011
Awaiting Public Summary
1 Feb 2008 to 31 Oct 2010
Awaiting Public Summary